Core Laboratories (CLB) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Amazon (AMZN) Misses Q3 EPS by 7c, Misses on Revenue; Offers Q4 Revenue Guidance
- Rivian shares slip ahead of Thursday earnings release
- Six killed in cyclone off India's eastern coast
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Core Laboratories (CLB) PT Raised to $26 at Cowen
July 24, 2020 8:06 AM EDTCowen analyst Marc Bianchi raised the price target on Core Laboratories (NYSE: CLB) to $26.00 (from $24.00) while maintaining a Market Perform rating.
... MoreCore Laboratories (CLB) PT Raised to $27 at RBC Capital
July 23, 2020 1:58 PM EDTRBC Capital analyst Kurt Hallead raised the price target on Core Laboratories (NYSE: CLB) to $27.00 (from $24.00) while maintaining an Outperform rating.
The analyst commented, "CLB continues to adhere to its long standing financial tenets of maximizing FCF, ROIC and returning excess... More



